KENOX PHARMACEUTICALS
Live / Registered — Registered (as of 24 Dec 2024)
What this means for you
Registered since 24 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97436436
- Registration number
- 7627008
- Mark type
- Design + words
- Filed
- 31 May 2022
- Published for opposition
- 11 Jul 2023
- Registered
- 24 Dec 2024
- Attorney of record
- Y. Jae Kim
Goods and services
- Class 042 — Scientific and technological services: Research and development services in the field of pharmaceutical preparations
Owner
- Kenox Pharmaceuticals Inc., South Plainfield, NJ, US
- Kenox Pharmaceuticals Inc., South Plainfield, NJ, US
- Kenox Pharmaceuticals Inc., South Plainfield, NJ, US
Prosecution history
- 24 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
- 01 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Oct 2024 — EXAMINERS AMENDMENT E-MAILED
- 01 Oct 2024 — SU-EXAMINER'S AMENDMENT WRITTEN
- 02 May 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 May 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 22 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Feb 2024 — NON-FINAL ACTION E-MAILED
- 22 Feb 2024 — SU - NON-FINAL ACTION - WRITTEN
- 26 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jan 2024 — USE AMENDMENT FILED